QT Imaging Debuts the QT Imaging-Olea Viewer

QT Imaging Holdings Inc. has launched the QTI Imaging-Olea Viewer, a product that provides a unified platform for viewing multiple breast imaging modalities, thus enabling clinicians to correlate findings across imaging sources and monitor patients longitudinally.

By reducing reliance on multiple software viewers, the system streamlines workflow, enhances clinical efficiency, and supports more informed patient management over time. QT Imaging developed the Viewer with Olea Medical, a provider of advanced imaging software solutions.

“Integrating quantitative, radiation-free QTscan data with mammography, digital breast tomosynthesis, MRI, and ultrasound in a single intuitive platform improves interpretive efficiency, strengthens diagnostic confidence, and supports a more comprehensive multimodality approach to breast evaluation,” QT Imaging Chief Medical Officer Dr. Bilal Malik stated.

QT Imaging’s Breast Acoustic CT system leverages advanced ultrasound tomography to deliver true 3D volumetric breast imaging without ionizing radiation or painful compression. Designed to provide quantitative, reproducible imaging data, the technology offers particular clinical value in women with dense breast tissue. Powered by Olea Medical’s visualization framework, the QT Imaging-Olea Viewer enables comprehensive analysis of QT Imaging datasets through advanced 3D rendering, quantitative assessment, and integrated AI/ML capabilities, including future automated lesion segmentation and computer-aided detection applications.

“Our collaboration with QT Imaging shows how advanced software and imaging innovation can seamlessly come together to benefit clinicians and patients alike,” Olea Medical Founder/CEO Faycal Djeridane said. “By integrating QT Imaging’s quantitative biomarkers into our advanced imaging platform, we’re enabling a data-rich, cohesive viewing experience that enhances diagnostic efficiency.”

The QT-Viewer was developed under a QT Imaging and Olea Medical collaboration announced earlier this year.

QT Imaging Holdings Inc. is a medical device company engaged in the research, development, and commercialization of imaging systems using low-frequency sound waves. The company’s strategy is predicated upon the fact that medical imaging is critical to detecting, diagnosing, and treating disease, and that it should be safe, affordable, accessible, and centered on the patient’s experience. Breast Acoustic CT is a trademark of a QT Imaging Holdings affiliate.

Olea Medical, a Canon Medical Systems Corporation company, is a medical imaging software provider specializing in advanced MR, CT, and ultrasound imaging post-processing solutions. Based in La Ciotat, France, the company has established its credibility through the clinical translation of technologies and long-standing partnerships with academic and clinical institutions worldwide. Olea Medical’s solutions combine artificial intelligence-assisted technologies with proprietary Bayesian algorithms and advanced optimization methods applied to medical imaging. As a result, Olea Medical claims to be a recognized player in standardized, vendor-neutral, advanced quantitative and qualitative imaging, supporting both morphological and functional analysis across MR, CT, and ultrasound imaging. By bringing complex mathematical models into routine clinical practice, Olea Medical enables easy access to accurate, robust imaging biomarkers, supporting enhanced diagnostic confidence, longitudinal analysis, and response-to-treatment assessment across a broad range of clinical applications.